FTC files for injunction against Airborne copycat
This article was originally published in The Tan Sheet
Executive Summary
The Federal Trade Commission requests a permanent injunction against supplement firm Improvita Health Products for "engaging in deceptive acts or practices in connection with the advertising, marketing, and sale of the Germ Defense line of products, which are purported to prevent, treat, or cure cold and flu," between 2005 and 2008, according to a complaint filed April 15 in the U.S. District Court for the Northern District of Ohio. FTC alleges the Cleveland-based firm's products "expressly or by implication" make certain unsubstantiated prevention and treatment claims. In its advertising the firm likens the products to Airborne, which also faced FTC scrutiny for making unsubstantiated claims (1"The Tan Sheet" Aug. 18, 2008, p. 8)
You may also be interested in...
FTC Settlement Looks To Ground Airborne Claims
Under a settlement with the Federal Trade Commission announced Aug. 14, the maker of Airborne dietary supplement products must cease unsubstantiated health-related claims and contribute up to $6.5 million to an existing consumer redress fund
Prestige Expands UK Eye Care Range In Response To Consumer Demand
A “great consumer response” to TheraTears in the UK leads Prestige Consumer Healthcare to add TheraTears 5-in-1 Irritation and Redness eye drops to the range.
Who’s Hired? Hikma Recruits New US Generics President
A flurry of top level recruitments made headlines in the past weeks, with the likes of Hikma, Lupin, and Viatris announcing new hires while focusing on their targets for the year.